Dr Valdez Rheumo

Las mejores ideas son las que confrontan tu intuición

Residente Reumatologia CMN 20 Nov

Internista con Esteroides

Horror autotoxicus

POCUS lover #echofirst

[NEJM @NEJM]

Presented at #EULAR2026:

Among patients with relapsed polymyalgia rheumatica, treatment with secukinumab plus a 24-week glucocorticoid taper resulted in a higher percentage of patients with remission than a glucocorticoid taper alone. Full phase 3 REPLENISH trial results: https://t.co/w1oD5ug1kJ

Editorial: Emerging Era for Polymyalgia Rheumatica and GCA — Interleukin-17A Targeting https://t.co/I13JtK01EA

Original Article in @NEJMEvidence: Secukinumab for Giant Cell Arteritis (phase 3 GCAptAIN trial) https://t.co/0dWjwDaEHs

@eular_org

[Roxana González @RoxOsler]

Large vessel vasculitis appears to be driven by a complex network involving IL-6, IFNγ, tissue-resident memory T cells and JAK-STAT signaling. #EULAR2026 #Vasculitis

[Ritasman Baisya @RitasmanB]

Nail fold capillaroscope teaching at EULAR 2026 @eular_org @EUSTAR_org

[JIM - Journal of Internal Medicine @JInternMed]

New article to read! Long-term efficacy of #rituximab versus intravenous cyclophosphamide for severe #ANCA-associated #vasculitis.

➡️ Multicenter REVEAL cohort study
➡️ Remission induction therapy
➡️ RTX is a more effective and safer treatment option

🔗https://t.co/IzVEahz4if

[Laurent ARNAUD @Lupusreference]

✅ Do you have #LUPUS and #BRAINFOG? If so, we would like to INVITE YOU to contribute to our research STUDY for the development of the Lupus Brain Fog Severity Scale - a questionnaire to assess the characteristics and severity of brainfog in lupus 🦋
LINK:https://t.co/dkraXKAuxO

[Rheumatology Quarterly @RheumQuarterly]

nice summary for #rheumatoid #arthritis associated #ild #lungfibrosis
- risks for RA-ILD ?
- HRCT patterns ?
- risks for PPF in RA-ILD

@firatromatoloji @RheumQuarterly @anarsiknotrofil @BunyaminKisacik @NeslihanGken7 @LastManStand85 @RheumNow
https://t.co/3B23vReiUc

[Rohit Aggarwal @docrota]

Anti-synthetase syndrome (ASyS): Consensus on nomenclature and abbreviation for anti-synthetase syndrome is now done. Everyone should use this nomenclature and abbreviation for the ASyS going forward: an IMACS project https://t.co/VZI7Qx77Tc

[NefroClass @NefroClassMx]

SGLT2i 📈 infecciones en DM2?
n=79,437 SGLT2i vs GLP-1RA:
• ITU 1 año: 10.0% vs 10.2%
RR: 0.98 (IC 95%: 0.94–1.03)
• GTI 1 año: 2.0% vs 0.7%
RR: 2.95 (IC 95%: 2.52–3.44) → casi 3x 📈

Conclusión: No ↑ ITU, sí↑ ITG (candidiasis, balanitis), al inicio.

DOI: 10.2337/dc24-2169

[Jonathan Chávez @JonathanNefro]

El nuevo algoritmo propuesto para guiar la descongestión mediante la natriuresis en falla cardíaca descompensada.

No consideraron a los iSGLT2 como coadyuvantes🤔

Eur J Heart Fail 2025
10.1002/ejhf.3632

[Cristina Macía @reumacia]

Excelente revisión 🗂️ de tratamientos de espondiloartritis
Acceso abierto 🔑 https://t.co/U9bqVO5aWF
@GRESSER_Espa @CEADE_ @ProftDr @tugbaizci

[NephroPOCUS @NephroP]

Interesting concept!
#POCUS #FOAMed #FOAMcc
🔗https://t.co/Y5NDWT9sh9

[Rheuma Doc @LastManStand85]

Treatment of Rheumatoid Arthritis (RA) associated Interstitial lung disease #ILD
2023 ACR/Chest Guideline
#Rheumatology #MedTwitter

[Dr Valdez Rheumo @Zadlev1]

@ComunidadRazer alguien ha tenido este error?

[Rheuma Doc @LastManStand85]

Potential investigations to consider for the diagnosis of Neuropsychiatric #SLE #Lupus
I find the Q-Albumin ratio especially helpful..
BUT Nothing replaces a good detailed history as part of your clinical work up 📑
#MedTwitter #Rheumatology
[Table from T.Yoshio et Okamoto]

[Dr Valdez Rheumo @Zadlev1]

PD insistiré en llamarles ppts

[Dr Valdez Rheumo @Zadlev1]

Bitácora de profesor:
Tercera clase y me sentí viejo...
Doc ya todas laa ppts se hacen en canvas, ya todo está ahi

[Pasion Basket @PasionBasketNBA]

Shaquille O’Neal (2’16 m) junto a Simone Biles (1’42m)

[Glomerulovers @glomerulovers]

(1) Buena noche Glomerulovers, hoy les presentamos el 🧵 No. 13 “Hallazgos Histopatológicos en Nefropatía Diabética” un tema obligado para nefrólogos e internistas.

[Rheuma Doc @LastManStand85]

Systemic Sclerosis associated antibodies and their associated cutaneous and SSc complications [S.R Johnson et al]
#Rheumatology #MedTwitter